A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/21/2006	WO2006086706A3 A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
12/21/2006	WO2006086065A3 Formula, system and method for treating urushiol induced contact dermatitis
12/21/2006	WO2006085141A3 Compositions and methods for treating or preventing hepadnaviridae infection
12/21/2006	WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006	WO2006076569A3 Bicyclic heterocycles as cannabinoid receptor modulators
12/21/2006	WO2006076222A3 Pharmaceutical formulations
12/21/2006	WO2006069159A3 Pharmaceutical compositions comprising amorphous benzimidazole compounds
12/21/2006	WO2006069154A3 Vitamin d receptor modulators
12/21/2006	WO2006068697A3 Compositions including iron
12/21/2006	WO2006065392A3 Cancer treatments
12/21/2006	WO2006064519A3 Dnazymes for inhibition of japanese encephalitis virus replication
12/21/2006	WO2006064217A3 PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF
12/21/2006	WO2006059063A3 Perfluorocarbon liquids as carcinogen
12/21/2006	WO2006058303A3 Modulators of muscarinic receptors
12/21/2006	WO2006057921A3 Piperidinyl piperidine tachykinin receptor antagonists
12/21/2006	WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
12/21/2006	WO2006047438A3 Insecticidal 3-(dihaloalkenyl) phenyl derivatives
12/21/2006	WO2006041941A3 Use of aromatase inhibitors for the treatment of ectopic pregnancy
12/21/2006	WO2006041831A3 Cyclic β-amino acid derivatives as factor xa inhibitors
12/21/2006	WO2006037106A3 Carboxy-amido-triazoles for the localized treatment of ocular diseases
12/21/2006	WO2006034235A3 Substituted quinoline and quinazoline inhibitors of quinone reductase 2
12/21/2006	WO2006033965A3 Nadph oxidase inhibition pharmacotherapies for obstructive sleep apnea syndrome and its associated morbidities
12/21/2006	WO2006031894A3 Methods of treating a disorder
12/21/2006	WO2006031683A3 Compositions containing uridine, and methods utilizing same
12/21/2006	WO2006023397A3 Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
12/21/2006	WO2006021443A3 Composition comprising an at1 receptor blocker and a macrolide t-cell immunomodulator
12/21/2006	WO2006018662A3 Aryl urea derivatives for treating obesity
12/21/2006	WO2006014999A3 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease
12/21/2006	WO2006014790A3 Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
12/21/2006	WO2006012237A3 Aripiprazole crystaline forms and associated methods
12/21/2006	WO2006009893A3 Cancer chemotherapy
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	WO2005118009A3 Transdermal delivery system for treatment of cognitive disorders
12/21/2006	WO2005115367A3 Modulation of neurotransmitter activity in neurons
12/21/2006	WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
12/21/2006	WO2005110417A8 Phycotoxins and uses thereof
12/21/2006	WO2005107871A3 Pyrroloquinoline quinone drugs for treatment of cardiac injury
12/21/2006	WO2005107773A8 Solid dosage form of wetted heparin
12/21/2006	WO2005105097A3 Pyridopyrimidines for treating inflammatory and other diseases
12/21/2006	WO2005099712A3 Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
12/21/2006	WO2005099666A3 Delayed release formulations of 6-mercaptopurine
12/21/2006	WO2005092856A8 Tetrahydrocarbazoles and derivatives
12/21/2006	WO2005080345A3 Imidazoline derivatives having cb1-antagonistic activity
12/21/2006	WO2005051303A3 Screening for synergistic compounds
12/21/2006	WO2005048929A3 Plant-derived protein extract compositions and methods
12/21/2006	WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma
12/21/2006	WO2005037193A3 Compositions of a cyclooxygenase-2 selective inhibitor administered under hypothermic conditions for the treatment of ischemic mediated central nervous system disorders or injury
12/21/2006	WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors
12/21/2006	WO2004100937B1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression
12/21/2006	WO2004092191A3 Polymeric oligonucleotide prodrugs
12/21/2006	WO2004078922A3 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/21/2006	US20060288437 Zinc finger-based drug-dependent gene regulation system
12/21/2006	US20060287539 Chemical intermediates for production of sibutramine
12/21/2006	US20060287538 Process for the preparation of amorphous calcium salt of atorvastatin
12/21/2006	US20060287536 Phenyl-thiophene type vitamin d receptor modulators
12/21/2006	US20060287528 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
12/21/2006	US20060287525 For post-chemotherapy or post-operative surgery nausea and vomitting; sustained release
12/21/2006	US20060287403 Method and Composition for Treatment of Inflammatory and Inflammation-related Disorders
12/21/2006	US20060287402 Cathepsin inhibitors
12/21/2006	US20060287401 Methods for treatment of cardiovascular disorders and diseases
12/21/2006	US20060287400 benign prostatic hyperplasia, prostate intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA),
12/21/2006	US20060287399 Use of analgesics to treat chronic pain using sodium channel modulators
12/21/2006	US20060287398 Useful as intermediates for production of optically active pharmaceuticals, agricultural chemicals, or industrial chemicals; produced through hydrolysis, especially biohydrolysis, of a 4-alkylthiazolidine-4-carboxamide
12/21/2006	US20060287397 Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
12/21/2006	US20060287396 4-aryl quinols and analogs thereof as therapeutic agents
12/21/2006	US20060287395 Pharmaceutical composition for the therapy of lower urinary tract symptoms
12/21/2006	US20060287394 Composition and method for treating macular disorders
12/21/2006	US20060287393 Novel compounds, their preparation and use
12/21/2006	US20060287392 Gabapentin compositions
12/21/2006	US20060287391 Phosphodiesterase inhibitor
12/21/2006	US20060287390 Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same
12/21/2006	US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases
12/21/2006	US20060287388 Materials and Methods for Treating Coagulation Disorders
12/21/2006	US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/21/2006	US20060287386 Benzo[b]furane and benzo[b]thiophene derivatives
12/21/2006	US20060287385 Contacting cell with hedgehog antagonist; moderator of cell proliferative, cell differentiation
12/21/2006	US20060287384 Lipoic acid concentrate
12/21/2006	US20060287383 Substance exhibiting antidepressant property
12/21/2006	US20060287382 2-(1H-indolylsulfanyl)-aryl amine derivatives
12/21/2006	US20060287381 Enhanced indolinone based protein kinase inhibitors
12/21/2006	US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287378 Novel pyrroles and imidazoles
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287376 2-bromoaniline and 2-chloroaniline derivatives; used to make indole compounds
12/21/2006	US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006	US20060287373 Cathepsin cysteine protease inhibitors
12/21/2006	US20060287372 Pharmaceutical preparations containing thiazolidinediones showing new therapeutic indications
12/21/2006	US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R,7S,8R,9R,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents
12/21/2006	US20060287370 Isoindolinone kinase inhibitors
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287368 Amide derivative of amlodipine
12/21/2006	US20060287367 Pyridoxamine for the treatment of diabetic kidney disease
12/21/2006	US20060287366 Treating pain using selective antagonists of persistent sodium current
12/21/2006	US20060287364 Methods of prevention of infection with HIV/AIDS, venereal disease and influenza
12/21/2006	US20060287363 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists
12/21/2006	US20060287362 Organic compounds
12/21/2006	US20060287361 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opoid receptors ligands
12/21/2006	US20060287360 Novel compounds
12/21/2006	US20060287359 Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases

1 ... 3955 3956 3957 3958 3959 3960 3961 3962 3963 3964 3965 3966 3967 3968 3969 3970 3971 3972 3973 3974 3975 ... 7860